CN111494498A - 一种辅助睡眠植物饮料及其制备方法和应用 - Google Patents
一种辅助睡眠植物饮料及其制备方法和应用 Download PDFInfo
- Publication number
- CN111494498A CN111494498A CN202010210038.7A CN202010210038A CN111494498A CN 111494498 A CN111494498 A CN 111494498A CN 202010210038 A CN202010210038 A CN 202010210038A CN 111494498 A CN111494498 A CN 111494498A
- Authority
- CN
- China
- Prior art keywords
- extract
- sleep
- water
- acanthopanax
- hawthorn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 56
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000000284 extract Substances 0.000 claims abstract description 99
- 241000196324 Embryophyta Species 0.000 claims abstract description 33
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 27
- 235000020234 walnut Nutrition 0.000 claims abstract description 27
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 26
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 23
- 108010010803 Gelatin Proteins 0.000 claims abstract description 22
- 229920000159 gelatin Polymers 0.000 claims abstract description 22
- 239000008273 gelatin Substances 0.000 claims abstract description 22
- 235000019322 gelatine Nutrition 0.000 claims abstract description 22
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 22
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 15
- 235000012907 honey Nutrition 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 7
- 235000020717 hawthorn extract Nutrition 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 42
- 241000758789 Juglans Species 0.000 claims description 26
- 238000001914 filtration Methods 0.000 claims description 15
- 210000000582 semen Anatomy 0.000 claims description 14
- 241001092040 Crataegus Species 0.000 claims description 12
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 12
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 12
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 12
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 12
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 12
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 12
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 12
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 12
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 12
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 235000007106 Crataegus suborbiculata Nutrition 0.000 claims description 9
- 241000073432 Crataegus suborbiculata Species 0.000 claims description 9
- 235000013202 a hawthorn Nutrition 0.000 claims description 9
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims description 7
- 206010022437 insomnia Diseases 0.000 claims description 7
- 108010052008 colla corii asini Proteins 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 238000002481 ethanol extraction Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000003809 water extraction Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 3
- 241001632410 Eleutherococcus senticosus Species 0.000 claims description 2
- 241000736075 Schisandra Species 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 18
- 241000721047 Danaus plexippus Species 0.000 abstract description 3
- 240000007049 Juglans regia Species 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 9
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 8
- 230000028527 righting reflex Effects 0.000 description 8
- 239000002994 raw material Substances 0.000 description 7
- 230000004622 sleep time Effects 0.000 description 7
- 230000008034 disappearance Effects 0.000 description 6
- 229960002275 pentobarbital sodium Drugs 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000004620 sleep latency Effects 0.000 description 5
- 238000003304 gavage Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 229960000796 barbital sodium Drugs 0.000 description 3
- FTOAOBMCPZCFFF-UHFFFAOYSA-N barbitone sodium Natural products CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 244000247747 Coptis groenlandica Species 0.000 description 2
- 235000002991 Coptis groenlandica Nutrition 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 235000020510 functional beverage Nutrition 0.000 description 2
- 230000000147 hypnotic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229960001412 pentobarbital Drugs 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 244000248825 Peltandra virginica Species 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013400 design of experiment Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- -1 phytosterol Natural products 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/42—Preservation of non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Insects & Arthropods (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Animal Husbandry (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Dermatology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种辅助睡眠植物饮料及其制备方法和应用,所述辅助睡眠植物饮料的成分包括:蜂蜜、白砂糖、五味子提取物、刺五加提取物、山楂提取物、核桃仁提取物和阿胶。本发明依据中医君臣佐使理论进行合理配伍,使保健饮料具有更好的风味、更强的辅助睡眠作用。
Description
技术领域
本发明涉及一种辅助睡眠植物饮料及其制备方法和应用。
背景技术
目前,由于环境,生活习惯的影响,如常见的有睡眠环境的突然改变(强光、噪声、高温)、睡前饮茶,饮咖啡,吸烟、摄入或接触某些物质或药物、睡眠卫生不当或情绪因素等,都可导致失眠的发生,已经成为影响健康的重大因素。相关治疗失眠药物,主要为西药的镇静剂,通过麻痹神经起到促进睡眠作用。有的效果不甚明显并且长期使用会带来一定的副作用,比如会出现精神不振、头疼和记忆力下降等情况。因此,目前急需建立更安全有效的方法。
中国专利网公开了一种缓解失眠症状的草本植物固体饮料及其制备方法(CN107088215A),其成分组成为小麦、甘草、大枣、百合、酸枣仁、山药、茯苓、龙眼、玫瑰花。而本发明以蜂蜜、白砂糖、五味子、刺五加、山楂、核桃仁、阿胶为原料,在成分上同其有明显的不同,加入了具有促进睡眠的刺五加、五味子、阿胶等成分;在实际应用上,本发明是植物饮料,同该专利固体饮料相比,直接可以饮用,口感好,适用性更广。
通过中国知网检索未发现相关以蜂蜜、白砂糖、五味子、刺五加、山楂、核桃仁、阿胶为原料制备辅助睡眠植物饮料的相关文献。但可以查到部分成分的相关文献:1.澄清型刺五加饮料生产工艺:该篇文献主要对饮料的生产工艺进行了阐述,没有提到饮料的具体功效;2.改善睡眠功能性饮料酒的开发:该篇文献主要以酸枣仁为原料制备改善睡眠保健酒,不是以水为基质的饮料,且研究的原料成分同本发明无关;3.黄连阿胶汤治疗失眠的临床研究:该文献表明黄连阿胶汤可以改善睡眠,表明阿胶同其他中药可以起到辅助睡眠作用;4.五味子功能饮料及保健葡萄酒的研制:该文献表明五味子可以改善睡眠提高免疫力。但保健酒限制了其应用的范围,且研究成分同本发明不同,仅是其中一种成分。
总之,通过检索专利和相关文献未见体现本发明的以蜂蜜、白砂糖、五味子、刺五加、山楂、核桃仁、阿胶为原料制备辅助睡眠植物饮料的文献和专利成果。
发明内容
本发明的目的在于,克服现有技术中的存在副作用及口感不好的缺点,进而提供一种辅助睡眠植物饮料,具有很好的口感,易服用,且具有很好的辅助睡眠功效。
为了达到上述目的,本发明采用了以下技术手段:
本发明提供一种辅助睡眠植物饮料,所述辅助睡眠植物饮料的成分包括:蜂蜜、白砂糖、五味子提取物、刺五加提取物、山楂提取物、核桃仁提取物和阿胶。
优选的,所述辅助睡眠植物饮料的各成分所占重量百分比为:蜂蜜3-5%、白砂糖3-5%、五味子提取物2-4%、刺五加提取物2-3%、山楂提取物3-5%、核桃仁提取物1-2%、阿胶2-4%,其余为水。
优选的,所述辅助睡眠植物饮料的各成分所占重量百分比为:蜂蜜3%、白砂糖3%、五味子提取物2%、刺五加提取物3%、山楂提取物3%、核桃仁提取物1%、阿胶2%,其余为水。
本发明还提供所述辅助睡眠植物饮料的制备方法,包括以下步骤:
(1)水提取
分别将刺五加、山楂、核桃仁粉碎,并分别加入到自身重量5~10倍的水中,煎煮1~5小时,煎煮1~3次,过滤,将各滤液浓缩,分别得到刺五加水提取物、山楂水提取物和核桃仁水提取物;
(2)乙醇提取
将五味子及步骤(1)得到的各水提取物分别加入到自身重量1~5倍的乙醇中,静置12~24小时,过滤,将各滤液浓缩,分别得到五味子提取物、刺五加提取物、山楂提取物和核桃仁提取物;
(3)配置饮料
将蜂蜜、白砂糖、五味子提取物、刺五加提取物、山楂提取物、核桃仁提取物和阿胶混按照比例混匀,用水定容到100%,过滤,杀菌,灌装,即得。
本发明还提供所述辅助睡眠植物饮料在制备治疗失眠药物中的应用。
本发明所涉及原料的作用及其功效为:
蜂蜜:含有丰富的维生素和矿物质,具有安神益智、舒缓安眠、缓解压力和紧张等作用,此外可以调节饮料的口感。
白砂糖:可以提供能量,改善饮料的口感。
五味子:五味子含有丰富的维生素、有机酸、类黄酮,植物固醇、木酚素等,可以调节中枢神经系统的兴奋和抑制过程,对于工作疲劳、睡眠不足、睡眠障碍、心悸紊乱等症状有明显的调节作用,对于提高记忆力也有一定的作用。
刺五加:含有丰富的皂苷和多糖等,可以直接作用于中枢神经系统,对于神经衰弱、失眠多梦、等症状,有明显的预防和调理作用。
山楂:山楂具有可以开胃、促进消化、治疗腹泻、降血脂、降血压等作用。
核桃仁:核桃仁富含有丰富的卵磷脂和维生素E,具有润肠通便、健脑益智的功效。对于肾虚、腰冷疼痛、须发早白、记忆力减退和消化不良等症状都有明显的作用。
阿胶:阿胶具有滋阴养血补虚,能强化钙素营养,维护神经功能等作用。还能增强中枢神经功能,稳定精神情绪,消除抑郁,紧张,烦躁,起到安神功效。
相较于现有技术,本发明的有益效果在于:
1、本发明遵循“君臣佐使”理论,以阿胶为君,以五味子、刺五加共为臣,以核桃仁为佐,以山楂为使,在配以蜂蜜、白砂糖具有更好的口感,五味子、刺五加等具有促进睡眠的作用,而阿胶、山楂、核桃仁等具有补血、补气、营养神经等作用,整体具有很好的辅助睡眠功效。
2、本发明通过动物实验睡眠功效评价证明可以有效地促进睡眠。
具体实施方式
下面结合具体实施例来进一步描述本发明,本发明的优点和特点将会随着描述而更为清楚。但这些实施例仅是范例性的,并不对本发明的范围构成任何限制。本领域技术人员应该理解的是,在不偏离本发明的精神和范围下可以对本发明技术方案的细节和形式进行修改或替换,但这些修改和替换均落入本发明的保护范围内。
实施例1
本实施例的辅助睡眠植物饮料的各成分所占重量百分比为:
蜂蜜3%、白砂糖3%、五味子提取物2%、刺五加提取物3%、山楂提取物3%、核桃仁提取物1%、阿胶2%,其余为水。
本实施例的辅助睡眠植物饮料的制备方法为:
(1)水提取
分别将刺五加、山楂、核桃仁粉碎,并分别加入到自身重量7倍的水中,煎煮3小时,煎煮2次,过滤,将各滤液浓缩,分别得到刺五加水提取物、山楂水提取物和核桃仁水提取物;
(2)乙醇提取
将五味子及步骤(1)得到的各水提取物分别加入到自身重量3倍的乙醇中,静置18小时,过滤,将各滤液浓缩,分别得到五味子提取物、刺五加提取物、山楂提取物和核桃仁提取物;
(3)配置饮料
将蜂蜜、白砂糖、五味子提取物、刺五加提取物、山楂提取物、核桃仁提取物和阿胶混按照比例混匀,用水定容到100%,过滤,杀菌,灌装,即得。
实施例2
本实施例的辅助睡眠植物饮料的各成分所占重量百分比为:
蜂蜜4%、白砂糖4%、五味子提取物3%、刺五加提取物3%、山楂提取物4%、核桃仁提取物2%、阿胶4%,其余为水。
本实施例的辅助睡眠植物饮料的制备方法为:
(1)水提取
分别将刺五加、山楂、核桃仁粉碎,并分别加入到自身重量5倍的水中,煎煮1小时,煎煮两次,过滤,将各滤液浓缩,分别得到刺五加水提取物、山楂水提取物和核桃仁水提取物;
(2)乙醇提取
将五味子及步骤(1)得到的各水提取物分别加入到自身重量1倍的乙醇中,静置12小时,过滤,将各滤液浓缩,分别得到五味子提取物、刺五加提取物、山楂提取物和核桃仁提取物;
(3)配置饮料
将蜂蜜、白砂糖、五味子提取物、刺五加提取物、山楂提取物、核桃仁提取物和阿胶混按照比例混匀,用水定容到100%,过滤,杀菌,灌装,即得。
实施例3
本实施例的辅助睡眠植物饮料的各成分所占重量百分比为:
蜂蜜5%、白砂糖5%、五味子提取物4%、刺五加提取物3%、山楂提取物5%、核桃仁提取物2%、阿胶4%,其余为水。
本实施例的辅助睡眠植物饮料的制备方法为:
(1)水提取
分别将刺五加、山楂、核桃仁粉碎,并分别加入到自身重量10倍的水中,煎煮5小时,煎煮两次,过滤,将各滤液浓缩,分别得到刺五加水提取物、山楂水提取物和核桃仁水提取物;
(2)乙醇提取
将五味子及步骤(1)得到的各水提取物分别加入到自身重量5倍的乙醇中,静置24小时,过滤,将各滤液浓缩,分别得到五味子提取物、刺五加提取物、山楂提取物和核桃仁提取物;
(3)配置饮料
将蜂蜜、白砂糖、五味子提取物、刺五加提取物、山楂提取物、核桃仁提取物和阿胶混按照比例混匀,用水定容到100%,过滤,杀菌,灌装,即得。
实验例
按照实施例1的辅助睡眠植物饮料配方配置成所需要浓度进行辅助睡眠实验。
1、实验设计
本实验包含3个部分。KM品系小白鼠90只,体重21~25g。将动物分成三个实验组,每组30只,分别进行延长戊巴比妥钠睡眠时间实验、戊巴比妥钠阈下剂量催眠实验和巴比妥钠睡眠潜伏期实验。每个实验分为3组,每组10只,分别为空白对照组(灌胃蒸馏水)、低剂量饮料组(灌胃低剂量饮料)和高剂量饮料组(灌胃高剂量饮料)。按照实施例1配方配置饮料的浓缩膏,人体推荐剂量为50ml/人/天(50ml/60kg·bw),相当于摄入浓缩膏12.5g/60kg,即0.208g/kg·bw。以人推荐剂量的10倍(2.08g/kg·bw)和30倍(6.25g/kg·bw)为低剂量和高剂量。低剂量和高剂量受试物配置时,分别取样品浓缩膏20.8g和62.5g加蒸馏水配置成100ml溶液。灌胃体积均为0.1ml/10g·bw,连续30天。
2、实验方法
(1)延长戊巴比妥钠睡眠时间试验
小鼠末次灌胃15min后,腹腔注射戊巴比妥钠50mg/kg(预实验得到的能使100%小鼠均能产生翻正反射消失的剂量)。以翻正反射消失至恢复时间为睡眠时间,记录各组小鼠睡眠时间。
(2)戊巴比妥钠阈下剂量催眠试验
小鼠末次灌胃15min后,腹腔注射戊巴比妥钠28mg/kg(预实验得到的能使90%小鼠翻正反射不消失的戊巴比妥钠阈下剂量),以翻正反射消失持续超过60s为入睡标志,记录30min内各组入睡动物数。
(3)巴比妥钠睡眠潜伏期试验
小鼠末次灌胃15min后,腹腔注射巴比妥钠240mg/kg(预实验得到的能使100%小鼠均能产生翻正反射消失的剂量),以翻正反射消失为入睡标志,记录动物睡眠潜伏期(由注射巴比妥钠到动物翻正反射消失所需时间)。
3、数据处理
睡眠时间属计量资料,采用t检验;入睡动物数属计数资料,采用卡方检验,组间比较P<0.05为有统计学意义。
4、实验结果
低剂量饮料组和高剂量饮料组小鼠在给予样品后,部分小鼠表现为安静和活动减少,但没有小鼠翻正反射消失,而阴性对照组动物全部清醒,提示受试物对动物无直接睡眠作用。此外,与空白对照组相比,饮料组小鼠睡眠时间延长、睡眠潜伏期时间缩短,差异有统计学意义(P<0.05)。实验数据参见表1。
表1饮料对小鼠改善睡眠的影响
*与对照组比较,有显著性差异P<0.05。
结果:本发明的辅助睡眠植物饮料能明显延长戊巴比妥钠诱导的小鼠睡眠时间、缩短巴比妥钠睡眠潜伏期,表明有促进睡眠的功效。
Claims (5)
1.一种辅助睡眠植物饮料,其特征在于,所述辅助睡眠植物饮料的成分包括:蜂蜜、白砂糖、五味子提取物、刺五加提取物、山楂提取物、核桃仁提取物和阿胶。
2.根据权利要求1所述的辅助睡眠植物饮料,其特征在于,所述辅助睡眠植物饮料的各成分所占重量百分比为:蜂蜜3-5%、白砂糖3-5%、五味子提取物2-4%、刺五加提取物2-3%、山楂提取物3-5%、核桃仁提取物1-2%、阿胶2-4%,其余为水。
3.根据权利要求1所述的辅助睡眠植物饮料,其特征在于,所述辅助睡眠植物饮料的各成分所占重量百分比为:蜂蜜3%、白砂糖3%、五味子提取物2%、刺五加提取物3%、山楂提取物3%、核桃仁提取物1%、阿胶2%,其余为水。
4.制备如权利要求1-3任一项所述的辅助睡眠植物饮料的方法,其特征在于,包括以下步骤:
(1)水提取
分别将刺五加、山楂、核桃仁粉碎,并分别加入到自身重量5~10倍的水中,煎煮1~5小时,煎煮1~3次,过滤,将各滤液浓缩,分别得到刺五加水提取物、山楂水提取物和核桃仁水提取物;
(2)乙醇提取
将五味子及步骤(1)得到的各水提取物分别加入到自身重量1~5倍的乙醇中,静置12~24小时,过滤,将各滤液浓缩,分别得到五味子提取物、刺五加提取物、山楂提取物和核桃仁提取物;
(3)配置饮料
将蜂蜜、白砂糖、五味子提取物、刺五加提取物、山楂提取物、核桃仁提取物和阿胶混按照比例混匀,用水定容到100%,过滤,杀菌,灌装,即得。
5.如权利要求1-3任一项所述的辅助睡眠植物饮料在制备治疗失眠药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010210038.7A CN111494498A (zh) | 2020-03-23 | 2020-03-23 | 一种辅助睡眠植物饮料及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010210038.7A CN111494498A (zh) | 2020-03-23 | 2020-03-23 | 一种辅助睡眠植物饮料及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111494498A true CN111494498A (zh) | 2020-08-07 |
Family
ID=71848146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010210038.7A Pending CN111494498A (zh) | 2020-03-23 | 2020-03-23 | 一种辅助睡眠植物饮料及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111494498A (zh) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1130998A (zh) * | 1995-03-10 | 1996-09-18 | 薛维民 | 核桃提取液营养膏及由其配制的核桃提取液营养奶 |
CN1579250A (zh) * | 2003-08-07 | 2005-02-16 | 山东福胶集团有限公司 | 阿胶健身饮及其制备方法 |
CN1685952A (zh) * | 2005-05-20 | 2005-10-26 | 王浩贵 | 一种核桃仁保健面条 |
CN1730062A (zh) * | 2005-08-02 | 2006-02-08 | 山东仙河药业有限公司 | 一种健脾补肾、宁心安神的中药组合物及制备方法 |
CN101015605A (zh) * | 2007-01-19 | 2007-08-15 | 东北虎药业股份有限公司 | 一种用于改善睡眠的保健食品及其制备方法 |
CN101766241A (zh) * | 2009-12-31 | 2010-07-07 | 邵伟 | 五加北五味红茶 |
CN101912014A (zh) * | 2010-09-03 | 2010-12-15 | 邵伟 | 五加山楂叶红茶 |
CN104397694A (zh) * | 2014-11-28 | 2015-03-11 | 哈尔滨墨医生物技术有限公司 | 一种改善睡眠刺五加五味子口服液及其生产方法 |
CN107126485A (zh) * | 2017-04-10 | 2017-09-05 | 哈尔滨医科大学 | 一种辅助改善睡眠的中药组合物及其制备方法和应用 |
CN108936168A (zh) * | 2018-09-19 | 2018-12-07 | 伊春五加参药业有限责任公司 | 一种改善睡眠的饮料及其制备工艺 |
CN109820915A (zh) * | 2019-04-01 | 2019-05-31 | 黑龙江双兰星制药有限公司 | 治疗神经衰弱、失眠症的无糖型安神宁口服液及其制备方法 |
-
2020
- 2020-03-23 CN CN202010210038.7A patent/CN111494498A/zh active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1130998A (zh) * | 1995-03-10 | 1996-09-18 | 薛维民 | 核桃提取液营养膏及由其配制的核桃提取液营养奶 |
CN1579250A (zh) * | 2003-08-07 | 2005-02-16 | 山东福胶集团有限公司 | 阿胶健身饮及其制备方法 |
CN1685952A (zh) * | 2005-05-20 | 2005-10-26 | 王浩贵 | 一种核桃仁保健面条 |
CN1730062A (zh) * | 2005-08-02 | 2006-02-08 | 山东仙河药业有限公司 | 一种健脾补肾、宁心安神的中药组合物及制备方法 |
CN101015605A (zh) * | 2007-01-19 | 2007-08-15 | 东北虎药业股份有限公司 | 一种用于改善睡眠的保健食品及其制备方法 |
CN101766241A (zh) * | 2009-12-31 | 2010-07-07 | 邵伟 | 五加北五味红茶 |
CN101912014A (zh) * | 2010-09-03 | 2010-12-15 | 邵伟 | 五加山楂叶红茶 |
CN104397694A (zh) * | 2014-11-28 | 2015-03-11 | 哈尔滨墨医生物技术有限公司 | 一种改善睡眠刺五加五味子口服液及其生产方法 |
CN107126485A (zh) * | 2017-04-10 | 2017-09-05 | 哈尔滨医科大学 | 一种辅助改善睡眠的中药组合物及其制备方法和应用 |
CN108936168A (zh) * | 2018-09-19 | 2018-12-07 | 伊春五加参药业有限责任公司 | 一种改善睡眠的饮料及其制备工艺 |
CN109820915A (zh) * | 2019-04-01 | 2019-05-31 | 黑龙江双兰星制药有限公司 | 治疗神经衰弱、失眠症的无糖型安神宁口服液及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103784611B (zh) | 一种具有改善睡眠帮助缓解压力的组合物及其应用 | |
US10335447B2 (en) | Solid beverage for conditioning Qi deficiency constitution and method for producing the same | |
CN104173493A (zh) | 一种具有改善睡眠作用的药物组合物及其制备方法与应用 | |
CN103966067A (zh) | 一种中药保健酒及其生产工艺 | |
CN104256632A (zh) | 一种改善睡眠的保健品 | |
CN110772595A (zh) | 一种药食同源组合物及其制备方法和应用 | |
CN104222861A (zh) | 一种治疗失眠的安神保健粥 | |
CN104382050A (zh) | 一种宁心安神、助睡眠的保健品 | |
CN103157036A (zh) | 一种具有美肌丰胸功效的保健中药 | |
CN101238894B (zh) | 具有改善睡眠功能的保健食品及其制备方法 | |
CN112316066B (zh) | 一种含茉莉花的安神助眠中药红糖及其制备方法 | |
CN111494498A (zh) | 一种辅助睡眠植物饮料及其制备方法和应用 | |
CN113599466A (zh) | 一种具有安神助眠功能的植物提取物 | |
CN100382832C (zh) | 一种用于改善女性更年期症状的保健食品 | |
CN113632979A (zh) | 一种男女通用的四季养生饮料及其制备方法 | |
CN114081171A (zh) | 一种具有辅助改善睡眠作用的功能性食品组合物 | |
CN112890173A (zh) | 一种具有改善睡眠质量的药食同源组合物及其应用 | |
KR20110101649A (ko) | 수면 유도용 조성물 | |
CN112439038A (zh) | 一种快速改善睡眠的药物 | |
CN106551225A (zh) | 一种饮料及其制备方法 | |
CN104419577A (zh) | 五味子葡萄酒 | |
CN110897119B (zh) | 一种改善睡眠质量的组合物 | |
US11771727B2 (en) | Traditional Chinese medicine composition and product for improving sleep by balancing yin and yang, method for making the same and use thereof | |
CN115814011B (zh) | 一种清心助眠益智药枕及其制备方法 | |
CN101856401B (zh) | 治疗失眠的外用中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200807 |